Tags: Health Topics | Diabetes | glucose monitor | abbott laboratories

FDA Approves New Version of Affordable Glucose Monitor

a freestyle libre sensor on someone's arm
A FreeStyle Libre sensor on someone's arm. (Navorolphotography/Dreamstime.com)

Monday, 15 June 2020 07:58 AM

The U.S. Food and Drug Administration on Monday cleared a new version of Abbott Laboratories' continuous glucose monitoring device, FreeStyle Libre, helping the company build upon the success of its fastest-growing diabetes product.

FreeStyle Libre 2, which was approved in Europe in 2018, will be priced the same as its precursor and is offered at a discount compared to rival devices, Abbott said.

The first generation of the device, which has brought in millions in sales for Abbott, allows diabetics to track their blood sugar levels without multiple daily finger sticks. It was launched in Europe in 2014 and three years later in the U.S.

Each sensor of the device, worn at the back of the upper arm for 14 days, is available at a list price of $54, while the handheld reader, used to scan the sensor, will be available for a one-time cost of $70.

Commercially insured patients will pay about $10 out-of-pocket per month for two sensors.

Worldwide sales of the Freestyle Libre device rose 58.5% to $534 million in the fourth quarter of 2019. The company last year said it planned to ramp up manufacturing capacity for the device by three to five times in the next few years.

FreeStyle Libre 2 would be produced on the same manufacturing lines as the first version, Jared Watkin, Abbott's senior vice president for diabetes care said.

© 2021 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
Health-News
The U.S. Food and Drug Administration on Monday cleared a new version of Abbott Laboratories' continuous glucose monitoring device, FreeStyle Libre.
glucose monitor, abbott laboratories
228
2020-58-15
Monday, 15 June 2020 07:58 AM
Newsmax Media, Inc.
 
Newsmax TV Live

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved